WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011141451) DNA BASED MULTIVALENT VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS, ENCODING AG85A, TB9.8, TB10.4 AND ACR2 ANTIGENS.
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/141451    International Application No.:    PCT/EP2011/057486
Publication Date: 17.11.2011 International Filing Date: 10.05.2011
IPC:
C12N 15/62 (2006.01), A61K 39/04 (2006.01)
Applicants: ISIS INNOVATION LIMITED [GB/GB]; University Offices, Wellington Square, Oxford Oxfordshire OX1 2JD (GB) (For All Designated States Except US).
HILL, Adrian Vivian Sinton [IE/GB]; (GB) (For US Only).
GILBERT, Sarah Catherine [GB/GB]; (GB) (For US Only).
MCSHANE, Helen [GB/GB]; (GB) (For US Only).
VODERMEIER, Martin [DE/GB]; (GB) (For US Only).
VILLAREAL-RAMOS, Bernardo [GB/GB]; (GB) (For US Only).
HEWINSON, Robert Glyn [GB/GB]; (GB) (For US Only).
Veterinary Laboratories Agency [GB/GB]; TB Research Group Department of Bacteriology Veterinary Laboratories Agency Weybridge Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB (GB) (For All Designated States Except US)
Inventors: HILL, Adrian Vivian Sinton; (GB).
GILBERT, Sarah Catherine; (GB).
MCSHANE, Helen; (GB).
VODERMEIER, Martin; (GB).
VILLAREAL-RAMOS, Bernardo; (GB).
HEWINSON, Robert Glyn; (GB)
Agent: Kilburn & Strode LLP; 20 Red Lion Street Holborn London Greater London WC1R 4PJ (GB)
Priority Data:
1007790.7 10.05.2010 GB
Title (EN) DNA BASED MULTIVALENT VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS, ENCODING AG85A, TB9.8, TB10.4 AND ACR2 ANTIGENS.
(FR) VACCIN À ADN MULTIVALENT CONTRE LA TUBERCULOSE À MYCOBACTÉRIES, CODANT POUR LES ANTIGÈNES AG85A, TB9.8, TB10.4 ET ACR2
Abstract: front page image
(EN)The present invention relates to immunogenic compositions comprising viral vectors capable of expressing novel combinations of antigens, fusion proteins comprising novel combinations of antigens and their use in the treatment and prevention of diseases such as tuberculosis.
(FR)La présente invention concerne des compositions immunogènes comprenant des vecteurs viraux capables d'exprimer de nouvelles combinaisons d'antigènes, des protéines de fusion contenant des nouvelles combinaisons d'antigènes et leur utilisation pour traiter et prévenir des maladies telles que la tuberculose.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)